Nitroglycerin and Heart transplant - a phase IV clinical study of FDA data

Summary:

Heart transplant is reported as a side effect among people who take Nitroglycerin (nitroglycerin), especially for people who are male, 20-29 old, also take Digoxin, and have Hypertriglyceridaemia.

The phase IV clinical study analyzes which people have Heart transplant when taking Nitroglycerin. It is created by eHealthMe based on reports of 52,631 people who have side effects when taking Nitroglycerin from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Heart transplant?

Heart transplant is found to be associated with 143 drugs and 235 conditions by eHealthMe. Check the latest studies of Heart transplant.

On Jul, 07, 2026

52,631 people reported to have side effects when taking Nitroglycerin.
Among them, 18 people (0.03%) have Heart transplant.

Could Nitroglycerin cause Heart transplant?

Among these 18 people:

What is the gender of people who have Heart transplant when taking Nitroglycerin? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Heart transplant when taking Nitroglycerin? *

What are other drugs people take besides Nitroglycerin? *

What are other side effects people have besides Heart transplant? *

Fatigue (feeling of tiredness): 10 people, 55.56%
Blood Glucose Increased: 10 people, 55.56%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 10 people, 55.56%
Pleural Effusion (water on the lungs): 9 people, 50.00%
Cardiac Failure Congestive: 9 people, 50.00%
Insomnia (sleeplessness): 8 people, 44.44%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 38.89%
Weight Decreased: 7 people, 38.89%
Fainting (loss of consciousness and postural tone): 7 people, 38.89%
High Blood Cholesterol: 7 people, 38.89%

What are the existing conditions these people have? *

Hypertriglyceridaemia (excess of triglycerides in the blood): 5 people, 27.78%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 22.22%
Depression: 4 people, 22.22%
Ill-Defined Disorder: 3 people, 16.67%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and have Heart transplant?

- Check whether Heart transplant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitroglycerin:

Nitroglycerin (52,884 reports)

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart transplant:

Heart transplant (143 drugs)

Browse all the conditions that are associated with Heart transplant:

Heart transplant (235 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitroglycerin) and Nitroglycerin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.